Enhanced Passive Safety Surveillance of VaxigripTetra® (Quadrivalent Inactivated Split Virion Influenza Vaccine, Intramuscular Route) and Efluelda® (Quadrivalent Inactivated Split Virion Influenza Vaccine, Intramuscular Route) Vaccines in Europe During the Influenza Season 2021/22.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05078060

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:39:15.146227+00:00

Published At

2023-03-24T00:00:00+00:00

Record Updated At

2023-03-24

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Influenza (Healthy Volunteers)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2023-03-24"

protocolSection.identificationModule.nctId

"NCT05078060"

protocolSection.identificationModule.officialTitle

"Enhanced Passive Safety Surveillance of VaxigripTetra\u00ae (Quadrivalent Inactivated Split Virion Influenza Vaccine, Intramuscular Route) and Efluelda\u00ae (Quadrivalent Inactivated Split Virion Influenza Vaccine, Intramuscular Route) Vaccines in Europe During the Influenza Season 2021/22."

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Influenza (Healthy Volunteers) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.